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Abstract Patients with abdominal aortic aneurysm
(AAA) frequently have other abdominal pathologies of
surgical interest (other diseases, OD). Out of 1,375 elective
open aortic replacements for AAA, 315 cases with OD
were subdivided in Group 1 (82 patients with ‘‘clean
wound’’ OD) and Group 2 (233 patients with ‘‘clean-con-
taminated wound’’ OD). The results of the sub-groups in
which OD was treated at the same time as AAA were
analysed (1a, 66 cases and 2a, 86 cases) and compared with
OD not treated at the same time as AAA (1b, 16 cases and
2b, 147 cases). EVAR was done in 12 patients with a in-
frarenal AAA and concomitant abdominal disease. In this
group post-operative complications occured in two patients
(endoleaks) and no sign of endograft infection was devel-
oped. Mean follow-up was 36 months. Mortality was 0% in
Group 1a, 1b, 2b and 5.8% in Group 2a. In Group 1a there
were one haemoperitoneum, one ischaemic colitis and one
graft infection. In Group 1b there were 4 nefrectomies for
renal carcinoma and three emergency hernia repairs within
18 months from AAA operation. In Group 2a the follow-up
was uneventful. In Group 2b there was no acute compli-
cation of OD and 57.2% of patients were subsequently
operated for OD. In the EVAR group the 30-day and late
mortality rates were 0 and 25%, respectively and all deaths
were cancer-related. Contemporary correction of OD in
open surgery for AAA should be performed in clean wound
cases, while clean-contaminated operations can be done
only in selected cases. EVAR is a valid alternative tech-
nique to open vascular surgery for the concomitant treat-
ment of aortic aneurysms and abdominal pathologies.
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Introduction
More and more frequently patients who have to undergo an
aortic replacement due to an abdominal aortic aneurysm
(AAA) are found to suffer from other abdominal patholo-
gies. When choosing the therapy, it is therefore necessary
to evaluate both risks and beneﬁts of a combined treatment
versus a treatment at two different times in consideration of
the benign or malignant nature of the pathology associated
with AAA; the risk of short term rupture must also be taken
in consideration as far as the aortic lesion is concerned.
Two aspects seem to be particularly important: (1) the
risk of infection of the aortic prosthesis, especially if the
two pathologies are treated at the same time, but also if
AAA is treated alone, when the associated pathology rep-
resents a potential septic focus; (2) the risk of a rapid
evolution of AAA towards rupture, theoretically favoured
by the biohumoral mechanisms generated by the laparo-
tomic surgical trauma, if it is decided to treat the non-
vascular pathology ﬁrst.
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now is to be conﬁrmed or if, otherwise, it needs to be
modiﬁed, the present paper reports short- and long-term
results, retrospectively recorded from a prospective data-
base, on 315 patients suffering from non-vascular pathol-
ogies associated with AAA, compared with the results
observed in 1,060 patients with AAA not suffering from
associated pathologies who were operated on in the same
period.
Patients and methods
Out of 1,375 elective aortic replacements for AAA con-
secutively carried out at the Surgical Clinic of the Brescia
University, with mean follow-up of 36 months, 315 cases
showed other pathologies of surgical interest along with
AAA. According to the published international guidelines
[1, 2], these patients were subdivided as follows in con-
sideration of the risk of infection connected with a surgical
repair of their pathologies:
Group 1 (clean wound): constituted by 82 patients with
associated pathologies allowing aseptic surgery (hernia,
incisional hernia, renal carcinoma, adrenal neoplasms), 66
of which (80%) were treated at the same time (Group 1a)
and 16 (20%) were not treated at the same time as aortic
replacement (Group 1b) (Table 1).
Group 2 (clean-contaminated wound): constituted by
233 patients suffering from associated pathologies, the
treatment of which would not allow to guarantee complete
asepsis (cholelitiasis, ileum, colon and appendix benign
and malignant pathologies, gastric carcinoma, prostate and
bladder neoplasms, ovarian cyst), 86 of which (37%) were
treated at the same time (Group 2a) and 147 (63%) were
not treated at the same time as the aortic replacement
(Group 2b) (Table 2).
A total of 152 (Group 1a and Group 2a) patients
underwent an aortic replacement and a contemporaneous
repair of the associated pathology, whilst in 163 cases, only
the aortic replacement was carried out. We considered a
minimum interval of 30 days between the two interven-
tions to deﬁne a treatment ‘‘staged’’. The clinical and
instrumental (abdominal US for all patients, annual CT for
patients operated for neoplasia) follow-up was 36 months.
Results
Group 1: associated pathologies treatable with surgery
not implying the risk of intraoperative contamination
(clean wound)
Group 1a: Out of 66 cases surgically operated on at the
same time for both pathologies, mortality was 0%. We
found two (3.0%) complications after 30 days: one hae-
moperitoneum case, in a patient who had undergone an
aortic replacement and a plastic surgery for umbilical hernia
that required surgical revision for haemostasis and drain-
age; one ischaemic colitis, healed with medical therapy, in a
patient who had undergone an aortic replacement and a
plastic surgery for a left inguinal hernia. During follow-up,
one case of infection was found in the third month (1.5%),
in a patient subjected to aortic replacement and ventral
hernia repair of periprosthesic abscess, only a surgical
drainage was carried out. This was clinically successful and
the patient had to periodically undergo CT for 3 years.
Group 1b: Three hernia repair interventions, one of
which urgent and two of which elective, were necessary in
the case of the 16 patients for whom it had been decided
Table 1 Group 1: pathologies allowing aseptic surgery
Associated pathologies Total Group 1a
(%)
Group 1b
(%)
Inguinal or inguinal-scrotal
hernia
34 27 (79.4) 7 (20.6)
Incisional hernia 20 20 (100) 0
Umbilical hernia 11 11 (100) 0
Jatal hernia 6 1 (1.7) 5 (8.3)
Epigastric hernia 1 1 (100) 0
Renal carcinoma 7 6 (85.7) 1 (14.3)
Adrenal metastasis 1 0 1 (100)
Adrenal benign diseases 2 0 2 (100)
Total 82 66 (80) 16 (20)
Table 2 Group 2: potentially septic pathologies
Associated pathologies Total Group 2a (%) Group 2b (%)
Cholelitiasis 107 57 (53) 50 (47)
Gallbladder adenomyosis 3 3 (100) 0
Diverticular disease 58 0 58 (100)
Meckel’s diverticulum 8 7 (87.5) 1 (12.5)
Appendix disorders 6 6 (100) 0
Benign haepatic pathology 5 0 5 (100)
Benign jejunoileal pathology 7 6 (86) 1 (14)
Ovarian cyst 1 1 (100) 0
Retroperitoneal angioma 1 1 (100) 0
Malignant haepatic neoplasia 7 3 (43) 4 (57)
Gastric carcinoma 4 2 (50) 2 (50)
Prostate carcinoma 15 0 15 (100)
Benign prostatic disease 3 0 3 (100)
Bladder carcinoma 8 0 8 (100)
Total 233 86 (37) 147 (63)
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123not to treat the associated pathology at the same time as the
aortic replacement. These operations took place, respec-
tively, 6, 12 and 18 months after the ﬁrst surgical opera-
tion; out of the other 13 patients, 4 suffering from
malignant [2] and benign [2] renal or adrenal tumours were
all operated on 1 month after the ﬁrst surgical operation,
with lesions showing no evolution during the time after the
ﬁrst observation.
Group 2: pathologies associated with surgical
operations implying the risk of intraoperative
contamination (clean-contaminated wound)
Group 2a: mortality in the 86 patients treated at the same
time for both pathologies was 5.8% (four myocardial
infarction and one multiple organ failure). Morbidity was
to 6.2% (5/81). Mortality and morbidity only occurred in
the 60 cases of cholecystectomy, none of which were in the
complicated phase and with no evident association between
cholecystectomy and negative events. No adverse event
took place after associated surgical operations carried out
for pathologies which appeared to be more risky. No fur-
ther complications arose during follow-up in the 81
patients released (excluding the ﬁve deceased).
Group 2b: no mortality and morbidity was recorded in
the 147 patients initially treated only for AAA. Surgical
operations or endoscopic procedures were needed for 83
patients out of 145 (57.2%) in the months following the
ﬁrst operation. There were no complications and no evi-
dence of the disease progression in oncologic cases: out of
50 patients known to suffer from cholelitiasis 12 were
subjected to cholecystectomy, out of which two were
urgent operations and 10 were elective; out of 15 patients
suffering from prostatic neoplasia, 8 underwent prostatec-
tomy, two endoscopic resection and ﬁve hormone therapy;
patients harbouring bladder neoplasm underwent cystec-
tomy in three cases and endoscopic treatment in ﬁve cases;
one patient suffering from gastric neoplasia was subjected
to gastrectomy 2 months after aortic replacement; out of
the four patients suffering from hepatic neoplasia, two
underwent chemoembolisation and two hepatic resection
during the second month after the ﬁrst operation; out of the
58 patients suffering from diverticular disease, 10 under-
went colic resection between the 10th and the 14th month
after the ﬁrst operation.
A statistical comparison between the results of Group 1
and Group 2 considers patients operated on for both
pathologies as well as patients operated on only for AAA
lead to signiﬁcant conclusions as far as mortality was
concerned: the ﬁve patients operated on for both patholo-
gies who died all belonged to Group 2a (p\0.05 with
respect to patients operated at the same time belonging to
Group 1a). Results concerning morbidity were similar. A
mortality rate of 3.25% and a morbidity of 4.6% were
observed in the 152 patients of both groups operated on at
the same time for both pathologies (Group 1a ? 2a). This
result was statistically similar to that of the 1,060 patients
(mortality 2.1% and morbidity 4.2%) operated on only for
aortic replacement and not suffering from associated
pathologies and slightly higher than the result observed in
patients suffering from both pathologies who had not
undergone contemporaneous treatment (Group 1b ? 2b).
As far as results during medium- and long-term follow-
up are concerned, only one case of prosthetic infection was
observed 3 months after the ﬁrst surgical operation in a
patient belonging to Group 1a. This indicates a total inci-
dence of such complication of 0.6% in the 152 patients
operated on at the same time (Group 1a ? 2a). This
complication was 0% in the patients suffering from other
pathologies not treated at the same time (Group 1b ? 2b):
this difference is not statistically signiﬁcant, neither it is
signiﬁcant when compared with the three cases (0.24%)
observed in 1,060 patients operated on for AAA not suf-
fering from other pathologies.
The total survival rate according to Kaplan–Meyer
corresponded to 92% after 3 years and to 88% after 5 years
for patients of Group 1a and patients of Group 2a operated
on for both pathologies, and this result is statistically
similar to the result obtained with the 1,060 patients (95
and 85%, respectively) who had undergone only aortic
replacement and who did not suffer from associated
pathologies.
EVAR was done in 12 patients, who had a infrarenal
AAA of C4.0 cm (range 4.0–7.9 cm; mean size 5.5 cm)
and concomitant abdominal disease or malignancy ame-
nable for curative treatment. All aneurysms operated with
\5 cm in diameter were saccular aneurysms with charac-
teristics of ‘‘Impending rupture’’ (blister, blebs).
In the EVAR group, the AAA and abdominal disease or
cancer were treated with one-stage procedure in six
patients (one inguinal hernia, one linfoma, one splenic
aneurysm, one cholelitiasis, two gastric carcinomas). The
others six patients underwent a two-stage treatment (two
renal carcinomas, one penis carcinoma, one linfoma, two
rectum cancers) (in all cases with two different hospital
admissions); in two, AAA was treated ﬁrst. Patients in the
EVAR group were followed up at 3, 6, 12 month and then
every year. No patients died perioperatively. Postoperative
complications (30-day and late morbidity) occurred in two
patients (leak 1A developed 2 days after the operation,
which required correction with ballooning; leak 2B
revealed by 1 month TC after endovascular repair, with
spontaneous resolution after 1 year). No sign of endograft
infection was developed.
The 30-day and late mortality rates were 0 and 25%,
respectively; all deaths were cancer-related.
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123Discussion
The choice of the therapeutic sequence in patients suf-
fering not only from aortic aneurysm but also from other
abdominal pathology of surgical interest must be take
into account the following general aspects which have a
purely theoretical value [3, 4]: the risk of septic con-
tamination in aortic prosthetic surgery must be reduced to
a minimum in consideration of the very high morbidity
and mortality associated with this complication. It is,
therefore, very important to consider whether to treat the
associated pathology by aseptic surgery or by surgery
implying no septic risks [5, 6]. On the other hand, in the
presence of neoplastic pathologies, it is important to
consider that the surgical trauma deriving from the aortic
replacement could have a negative impact on the immune
system of the patient and therefore favour the progression
and the diffusion of the non-treated neoplasia [7–13].
Furthermore, if an aortic replacement is carried out
without treating the associated pathology, speciﬁc com-
plications could arise from the latter. Finally, if it is
decided to postpone the aortic replacement and to treat
the associated pathology ﬁrst, the laparotomic trauma
could increase the risk of rupture of the abdominal
aneurysm [9].
As far as abdominal wall pathologies and, in general, all
potentially non-septic pathologies are concerned, our and
other experiences [6–8] show that parietal plastic surgery
does not increase the risk of complications and does not
increase the rate of prosthetic superinfections. The para-
lytic ileum period and the gradual recovery of intestinal
motility, always present after aortic replacement, can
favour hernial complications, requiring a repeated urgent
surgery, and therefore, cause possible infection foci.
However, we postpone the parietal plastic surgery in 16 of
our patients operated on for difﬁcult aortic replacement
requiring a prolonged anaesthesia.
In the case of neoplasia with a low septic risk, con-
temporaneous treatment seems to be even more appropriate
as it avoids the risk of neoplastic progression or, vice versa,
of AAA rupture. A typical example is nephrectomy for
carcinoma: many Authors agree in proposing the con-
comitant treatment of AAA and renal carcinoma, because
this procedure does not increase mortality and morbidity
[3, 14–17], especially performing the nephrectomy in the
ﬁrst part of the operation [3, 16–18]. If partial nephrectomy
is carried out, it seems, however, more prudent to carry out
surgery at two different times, to reduce prosthesis con-
tamination by possible urinary leak from the residual
parenchymal. In our experience, the six nephrectomies and
the upper polar resection carried out for neoplasia at the
same time as aortic replacement did not lead to either
immediate or long-term complications.
In case of associated potentially septic pathologies, the
choice of the most appropriate timing is more complex,
related to higher risks of aortic prosthesis infection. In our
86 patients in Group 2a, morbidity, including the risk of
prosthesis infection, was not statistically different from
patients in Group 1a or from the 1,060 patients operated
only for AAA. However, mortality was completely dif-
ferent in this group: 5 patients out of 86 died (5.8%). This
problem is relevant in patients with benign disease of the
gallbladder, because biliary contamination represents a
frightening cause of infection of the aortic prosthesis; we
have also to consider the risk of acute cholecystitis after the
aortic replacement. Several authors reported very high
percentages of such septic complications which were par-
ticularly dangerous for the possible direct diffusion of the
sepsis to the aortic prosthesis before its healing. Cadot et al.
[19] report even an incidence of cholecystitis of up to 18%
after the endovascular treatment of aneurysm. It is there-
fore probably appropriate to have an eclectic attitude in the
choice of the therapeutic strategy. In our experience, we
have not observed immediate and long-term septic com-
plications. Other authors propose to proceed to cholecys-
tectomy by video-assisted laparoscopy and then to carry
out aortic replacement with an extraperitoneal approach,
possibly by means of ‘‘gasless laparoscopy’’ to reduce the
risk of acute evolution of AAA which could be favoured by
the pneumoperitoneum [20, 21]. In our opinion, the lapa-
roscopic approach has to be chosen for cholecystectomy in
the case of surgery carried out at different times.
Frequently diverticular diseases of the colon not sus-
pected of in the pre-operatory phase are found. In these
cases, the choice is very clear: surgery cannot take place
contemporaneously because of the elevate risk of direct
endogenous contamination. If a complicated diverticulosis
needing treatment is known before the aortic aneurysm
diagnosis, the prosthetic replacement surgery must be
carried out time after colic resection. In our experience one
patient operated on for a large AAA suffering from dif-
fused diverticular pathology ignored until the time of the
operation showed a colon perforation in a very early stage
(seventh day); he was subjected to urgent operation with an
Hartmann’s procedure and had a regular post-operative
course and he is healthy 44 months after operation.
In no case did we carry out an aortic replacement at the
same time as the treatment of malignant bladder and
prostate pathologies. In these cases the risks connected
with the two associated pathologies are determinant to
deﬁne the best timing for surgery which should be carried
out at different times at a distance of at least 3–6 months.
The association of aortic aneurysm and malignant gas-
trointestinal neoplasia put a more complex choice con-
cerning the surgical timing. As far as of colon cancer and
gastric cancer are concerned, quite concordant opinions
128 Updates Surg (2012) 64:125–130
123seem to be found the available literature [22, 23]: in the
presence of abdominal aortic aneurysm with a high risk of
impending rupture and asymptomatic colon neoplasia (not
in an advanced stage and without the risk of short-term
complications), it is recommended to treat the aortic
pathology ﬁrst; in the presence of abdominal aortic aneu-
rysm with a medium diameter associated with an advanced
stage colon neoplasia (with high risk of complications like
intestinal occlusion or perforation in short time), it is rec-
ommended to treat colic pathology ﬁrst [4, 24, 25]; in the
presence of an abdominal aortic aneurysm with a high risk
of rupture and of colon neoplasia in an advanced stage, the
choice of the surgical ‘‘timing’’ certainly is more complex;
in fact, some authors believe that a contemporaneous
treatment of the two pathologies with one surgical opera-
tion [25] could be taken into consideration. We observed
two cases of gastric neoplasia: one of these was in a very
advanced stage and associated with an AAA with a
diameter of[6 cm presenting a high risk of rupture in the
short term. In this case, we decided to treat the two lesions
at the same time. We believe, however, that this option
should represent an absolute exception, even though in our
speciﬁc case, we had a regular post-operative course
without complications over the successive 36 months of
follow-up.
These considerations appear to be quite obvious for
‘‘open’’ aortic surgery, but we think that they are valid
also for endovascular aortic repair (EVAR); more cases of
aortic endoprosthesis infection are reported in the litera-
ture [26–29]. In the last few years, several authors pub-
lished their sporadic experience with the treatment of
AAA through EVAR and of associated abdominal
pathologies: eight cases of AAA associated with colon
neoplasia operated on at two different times [30–33] and
one case treated at the same time by endovascular
exclusion of the aneurysm and successive colic resection.
Veraldi and colleagues [34] report their experience both
with open and endovascular treatment of abdominal
aneurysm in association with colic resection for neoplasia
and declare that they consider EVAR as an ideal treat-
ment (possibly in one stage at the same time as the
associated pathology) because of a lower risk of infection.
In addition, Suffat and colleagues [35] report their expe-
rience with three cases of AAA associated with a
malignant colic pathology and recommend EVAR in the
ﬁrst stage followed by colic resection a few days after the
absence of relevant complications has been ascertained.
We agree with Porcellini and Jesse [13, 36], reviewing its
cases from 1997 to 2005, which consider EVAR as a
valid alternative technique to open vascular surgery for
the concomitant treatment of aneurysmatic and tumoral
pathologies.
Conclusions
In our experience, any combined surgery for the treatment
of aneurysm abdominal aortic pathologies concomitant
with other pathologies involves a higher surgical risk;
therefore, it is important to assess the risk/beneﬁt ratio of a
contemporaneous versus double surgical treatment. Oper-
ation strategy and technique must be perfect to avoid sur-
gical complications; since, in case of adverse outcomes, the
surgeon would have to justify his aggressive choice.
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